[1] Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis,2003,23(1):47-58. [2] 中华医学会传染病与寄生虫病学分会和肝病学分会. 病毒性肝炎防治方案. 中华肝脏病杂志,2000,8(6):324-329. [3] 中华医学会肝病学分会、感染病学分会.慢性乙型肝炎防治指南. 实用肝脏病杂志,2006,9(1):8-18. [4] Fukuda R,Ishimura N,Nguyen TX,et al. The expression of IL-2,IL-4 and interferon-gamma(IFN-gamma) mRNA using liver biopsies at different phases of acute exacerbation of chronic hepatitis B. Clin EXP Immunol,1995,100(3):446-451. [5] Sakaguchi S,Sakaguchi N,Asano M,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol,1995,155(3):1151-1164. [6] Deaglio S,Dwyer KM,Gao W,et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med,2007,204(6):1257-1265. [7] Wing K,Onishi Y,Prieto-martin P,et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science,2008,322(5899):271-275. [8] Stoop JN,Vander molen RG,Baan CC,et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology,2005,41(4):771-778. [9] Zhang LJ,Wang XZ. Interleukin-10 and chronic liver disease. World J Gastroenterol,2006,12(11):1681-1685. [10] 马东瑞,王燕,袁东红,等. Th2类细胞因子与乙型肝炎病毒相关性肝病的关系. 细胞与分子免疫学杂志,2008,24(6):608-609. [11] Li WY,Jiang YF,Jin QL,et al. Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection. J Biomed Biotechnol,2010,20(10):138-141. [12] Xing T,Li L,Cao H,et al. Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. Clin Exp Immunol,2007,147(1):184-188. (校对:陈从新) |